{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-126231","form_type":"8-K","ticker":"ZBH","cik":"0001136869","company_name":"ZIMMER BIOMET HOLDINGS, INC.","filed_at":"2025-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.624126+00:00","generated_at":"2026-05-20T10:13:58.149476+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Zimmer Biomet appoints Kevin Thornal as Group President, Global Businesses and the Americas effective July 1, 2025","bullets":["Thornal appointed to new role effective July 1; reports to CEO Ivan Tornos, leads Americas and global business units.","Former Nevro CEO and Hologic Group President; previously held leadership at Stryker.","Mark Bezjak remains President Americas but ceases as executive officer upon Thornal's start.","Compensation: $850k base, 100% target bonus, ~$5.3M in equity (RSUs + PRSUs); eligible for severance plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-126231","json":"https://secwatch.observer/filing/0001193125-25-126231.json","markdown":"https://secwatch.observer/filing/0001193125-25-126231.md","text":"https://secwatch.observer/filing/0001193125-25-126231.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/0001193125-25-126231-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/d854072d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T10:13:58.149476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a82f18de0","claim":"Kevin Thornal was appointed as Group President, Global Businesses and the Americas at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Kevin Thornal has been appointed to the newly-created position of Group President, Global Businesses and the Americas of the Company, effective July 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/0001193125-25-126231-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Group President, Global Businesses and the Americas"}],"fact_type":"executive_change"},{"claim_id":"95978a97ae","claim":"Mark Bezjak departed as President, Americas at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Mark Bezjak, President, Americas, will continue to hold such office but will cease to be an executive officer of the Company at the time Mr. Thornal joins the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525126231/0001193125-25-126231-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be an executive officer"},{"label":"Role","value":"President, Americas"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}